
The Bayer G4A Startup Acceleration Program isn’t just about what you’re building. It’s equally about how far you can take it with the right support.
In its 9th Batch, the program—implemented in Türkiye together with Tenity—brings together startups working in Pharmaceuticals, Consumer Health, and Crop Science, and pairs them with hands-on mentorship, industry access, and concrete collaboration opportunities.
This is a program for startups that have moved beyond ideas and are now asking bigger questions: How do we validate faster? Who do we build with? How do we scale responsibly?
What Startups Gain from Bayer G4A
Before diving into the focus areas, here’s what founders consistently value most about the program:
The goal is simple: help startups move faster, smarter, and with fewer blind spots.
Where Your Solution Fits
💊 Pharmaceuticals: Improving Care Across the Journey
In Pharmaceuticals, the program focuses on solutions that improve access to treatment, patient experience, and clinical efficiency—especially in Cardiology, Women’s Health, Ophthalmology, and Oncology.
Startups in this space often work on:
With Bayer’s domain expertise and mentor access, startups can test assumptions, refine use cases, and build solutions that fit real healthcare workflows.
🏥 Consumer Health: From Access to Actionable Insight
In Consumer Health, the emphasis is on digital access, smarter operations, and better engagement.
Relevant solutions include:
Startups benefit from working closely with experts who understand scale, regulation, and complex consumer ecosystems—helping transform promising tools into deployable solutions.
🌱 Crop Science: Turning Data into Decisions
Crop Science solutions in Bayer G4A focus on precision, efficiency, and data-driven agriculture.
This includes technologies that:
With access to real industry perspectives, startups can sharpen their value proposition and ensure their technology delivers practical impact in the field.
Who Should Apply?
The Bayer G4A Startup Acceleration Program is built for startups that:
Selected startups are evaluated by a jury of Bayer mentors, Bayer executives, and Tenity, and then join a program designed to combine industry insight, structured acceleration, and financial support.
Applications Are Open
Applications for the 9th Batch of the Bayer G4A Startup Acceleration Program are open until February 1, 2026.
If you’re building in Pharmaceuticals, Consumer Health, or Crop Science and want to strengthen your product with real industry collaboration—not just feedback—this program is built for you.